Chittepu VC[au] - Search Results

Year	Number of Results
2018	2
2019	3
2020	1
2021	2
2022	1

1

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.

Zhu S, Ma AH, Zhu Z, Adib E, Rao T, Li N, Ni K, Chittepu VCSR, Prabhala R, Garisto Risco J, Kwiatkowski D, Mouw K, Sonpavde G, Cheng F, Pan CX. Zhu S, et al. Among authors: chittepu vcsr. J Immunother Cancer. 2021 Nov;9(11):e002917. doi: 10.1136/jitc-2021-002917. J Immunother Cancer. 2021. PMID: 34725212 Free PMC article.

2

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy.

Pan K, Farrukh H, Chittepu VCSR, Xu H, Pan CX, Zhu Z. Pan K, et al. Among authors: chittepu vcsr. J Exp Clin Cancer Res. 2022 Mar 31;41(1):119. doi: 10.1186/s13046-022-02327-z. J Exp Clin Cancer Res. 2022. PMID: 35361234 Free PMC article. Review.

3

Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors.

Kalhotra P, Chittepu VCSR, Osorio-Revilla G, Gallardo-Velazquez T. Kalhotra P, et al. Among authors: chittepu vcsr. Molecules. 2021 Feb 10;26(4):936. doi: 10.3390/molecules26040936. Molecules. 2021. PMID: 33578831 Free PMC article.

4

Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus.

Kalhotra P, Chittepu VCSR, Osorio-Revilla G, Gallardo-Velazquez T. Kalhotra P, et al. Among authors: chittepu vcsr. Biomolecules. 2020 Feb 14;10(2):305. doi: 10.3390/biom10020305. Biomolecules. 2020. PMID: 32075130 Free PMC article.

5

New Molecular Insights into the Inhibition of Dipeptidyl Peptidase-4 by Natural Cyclic Peptide Oxytocin.

Chittepu VCSR, Kalhotra P, Osorio-Gallardo T, Jiménez-Martínez C, Torre RRR, Gallardo-Velazquez T, Osorio-Revilla G. Chittepu VCSR, et al. Molecules. 2019 Oct 28;24(21):3887. doi: 10.3390/molecules24213887. Molecules. 2019. PMID: 31661941 Free PMC article.

6

Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study.

Chittepu VCSR, Kalhotra P, Osorio-Gallardo T, Gallardo-Velázquez T, Osorio-Revilla G. Chittepu VCSR, et al. Pharmaceutics. 2019 May 17;11(5):238. doi: 10.3390/pharmaceutics11050238. Pharmaceutics. 2019. PMID: 31108878 Free PMC article.

7

Discovery of Galangin as a Potential DPP-4 Inhibitor That Improves Insulin-Stimulated Skeletal Muscle Glucose Uptake: A Combinational Therapy for Diabetes.

Kalhotra P, Chittepu VCSR, Osorio-Revilla G, Gallardo-Velázquez T. Kalhotra P, et al. Among authors: chittepu vcsr. Int J Mol Sci. 2019 Mar 11;20(5):1228. doi: 10.3390/ijms20051228. Int J Mol Sci. 2019. PMID: 30862104 Free PMC article.

8

Designed Functional Dispersion for Insulin Protection from Pepsin Degradation and Skeletal Muscle Cell Proliferation: In Silico and In Vitro Study.

Chittepu VCSR, Kalhotra P, Gallardo-Velázquez T, Robles-de la Torre RR, Osorio-Revilla G. Chittepu VCSR, et al. Nanomaterials (Basel). 2018 Oct 19;8(10):852. doi: 10.3390/nano8100852. Nanomaterials (Basel). 2018. PMID: 30347680 Free PMC article.

9

Structure⁻Activity Relationship and Molecular Docking of Natural Product Library Reveal Chrysin as a Novel Dipeptidyl Peptidase-4 (DPP-4) Inhibitor: An Integrated In Silico and In Vitro Study.

Kalhotra P, Chittepu VCSR, Osorio-Revilla G, Gallardo-Velázquez T. Kalhotra P, et al. Among authors: chittepu vcsr. Molecules. 2018 Jun 6;23(6):1368. doi: 10.3390/molecules23061368. Molecules. 2018. PMID: 29882783 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results